Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients
- PMID: 12136229
- DOI: 10.1007/s00439-002-0769-4
Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients
Abstract
Heme oxygenase is a rate-limiting enzyme in heme degradation, leading to the generation of free iron, biliverdin, and carbon monoxide. Induction of heme oxygenase-1 is implicated in the antioxidant defense mechanism and can modulate vascular function. To test the association of microsatellite polymorphism in the promoter region of human HO-1 gene with the risk of coronary artery disease (CAD) in type 2 diabetic patients, we examined the allele frequencies of (GT) (n) repeats in HO-1 gene in 474 patients with CAD and in 322 controls. A transient-transfection assay with HO-1 promoter/luciferase fusion constructs carrying various lengths of (GT) (n) repeats was performed to explore the regulatory effect of (GT) (n) repeats on HO-1 gene expression in cultured rat aortic smooth muscle cells. Serum thiobarbituric acid-reactive substances (TBARs), a measure of lipid peroxidation, was significantly higher in subjects carrying the L/L genotype (> or =32 repeats). Among type 2 diabetic subjects, the frequencies of the L alleles and proportion of genotypes with L alleles were significantly higher in those with CAD than in those without CAD. The adjusted odds ratio for CAD in type 2 diabetic patients with L alleles was 4.7 (95% confidence interval, 1.9-12.0, P=0.001). Transfection experiments in aortic smooth muscle cells revealed that HO-1 promoter/luciferase fusion constructs containing longer (GT) (n) repeats exhibited lower transcriptional activity. These results imply that the length polymorphism in the HO-1 gene promoter modulate the transcription of the gene in vascular cells. Type 2 diabetics carrying longer (GT) (n) repeats might have higher oxidative stress and increased susceptibility to the development of CAD.
Similar articles
-
Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.Am J Hum Genet. 2000 Jan;66(1):187-95. doi: 10.1086/302729. Am J Hum Genet. 2000. PMID: 10631150 Free PMC article.
-
Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors.Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1680-5. doi: 10.1161/01.atv.0000033515.96747.6f. Arterioscler Thromb Vasc Biol. 2002. PMID: 12377749
-
The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.Chin Med J (Engl). 2005 Sep 20;118(18):1525-32. Chin Med J (Engl). 2005. PMID: 16232329
-
Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis.Am J Epidemiol. 2010 Sep 15;172(6):631-6. doi: 10.1093/aje/kwq162. Epub 2010 Aug 2. Am J Epidemiol. 2010. PMID: 20682519 Review.
-
The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism.Tohoku J Exp Med. 2003 Aug;200(4):167-86. doi: 10.1620/tjem.200.167. Tohoku J Exp Med. 2003. PMID: 14580148 Review.
Cited by
-
SNP (A > G - rs13057211) but not GT(n) polymorphism in HMOX-1 promotor gene is associated with COVID-19 mortality.BMC Pulm Med. 2023 Dec 21;23(1):514. doi: 10.1186/s12890-023-02785-x. BMC Pulm Med. 2023. PMID: 38129860 Free PMC article.
-
Phenotypic Associations With the HMOX1 GT(n) Repeat in European Populations.Am J Epidemiol. 2024 May 7;193(5):718-726. doi: 10.1093/aje/kwad154. Am J Epidemiol. 2024. PMID: 37414746 Free PMC article.
-
Heme oxygenase 1 in erythropoiesis: an important regulator beyond catalyzing heme catabolism.Ann Hematol. 2023 Jun;102(6):1323-1332. doi: 10.1007/s00277-023-05193-7. Epub 2023 Apr 12. Ann Hematol. 2023. PMID: 37046065 Review.
-
Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?Int J Mol Sci. 2022 Jun 29;23(13):7247. doi: 10.3390/ijms23137247. Int J Mol Sci. 2022. PMID: 35806251 Free PMC article.
-
HMOX1 genetic polymorphisms and outcomes in infectious disease: A systematic review.PLoS One. 2022 May 12;17(5):e0267399. doi: 10.1371/journal.pone.0267399. eCollection 2022. PLoS One. 2022. PMID: 35551540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous